Repigmentation of acral vitiligo with tofacitinib combined with NB‐UVB phototherapy: A case report
Australasian Journal of Dermatology · 2023
DOI: 10.1111/ajd.14147 ↗Kurz gefasst
Fallbericht in der Zeitschrift Australasian Journal of Dermatology, 2023. Verfasst von Xiu-Kun Sun und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Hangzhou Third People's Hospital, Affiliated Hangzhou Dermatology Hospital of Zhejiang University School of Medicine, Hang…. Hauptthemen laut MEDLINE: Vitiligo, Ultraviolet Therapy, Hypopigmentation. Die Arbeit nennt 5 Literaturangaben. Gefördert von: National Natural Science Foundation of China Joint Fund Project, National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Hangzhou Third People's Hospital, Affiliated Hangzhou Dermatology Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Förderung
- National Natural Science Foundation of China Joint Fund Project
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
Sun, X. K., & Xu, A. E. (2023). Repigmentation of acral vitiligo with tofacitinib combined with NB‐UVB phototherapy: A case report. Australasian Journal of Dermatology. https://doi.org/10.1111/ajd.14147
Vancouver
Sun XK, Xu AE. Repigmentation of acral vitiligo with tofacitinib combined with NB‐UVB phototherapy: A case report. Australasian Journal of Dermatology. 2023. doi:10.1111/ajd.14147
BibTeX
@article{Sun2023,
author = {Sun, Xiu-Kun and Xu, Ai-E},
title = {Repigmentation of acral vitiligo with tofacitinib combined with NB‐UVB phototherapy: A case report},
journal = {Australasian Journal of Dermatology},
year = {2023},
doi = {10.1111/ajd.14147}
}
EUVIMED